Sushmita Ghosh

发表

Mitotic checkpoint defects: en route to cancer and drug resistance

Tanuma Mistry, Ranita Pal, Vilas D. Nasare, 2021, Chromosome Research.

PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer

Tanuma Mistry, Ranita Pal, Vilas D. Nasare, 2022, Medical Oncology.

Novel 1,2,3-triazole-aurone hybrids as cathepsin B inhibitors: One-pot synthesis, anti-proliferative, and drug modeling studies

Vilas D. Nasare, M. Kumari, N. Raghav, 2022, European Journal of Medicinal Chemistry Reports.

Mitotic checkpoint defects: en route to cancer and drug resistance

T. Bera, D. Ghosh, P. Sahoo, 2021, Chromosome Research.

Ultrasound assisted a one pot multicomponent and greener synthesis of 1,2,3-triazole incorporated aurone hybrids: Cathepsin B inhibition, anti-cancer activity against AGS cell line, and in-silico docking evaluation

Vilas D. Nasare, M. Kumari, N. Raghav, 2022, Current Research in Green and Sustainable Chemistry.

Synthesis, cytotoxic evaluation and structure activity relationship of pyrazole hybrid aurones on gastric cancer (AGS) cell lines

Suresh Kumar, Sanjeev Kumar, Sushmita Ghosh, 2022, Results in Chemistry.

Evaluation of numerical rating scale and neuropathic pain symptom inventory pain scores in advanced ovarian carcinoma patients undergoing surgery and first-line chemotherapy

Vilas D. Nasare, M. Vernekar, S. Mandal, 2022, Journal of clinical and translational research.

Cytogenetic variations in a series of cases of Down Syndrome

R. Kundu, Sanchita Roy, Sushmita Ghosh, 2015 .

Outcomes of 3-year follow up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study.

P. Sahoo, Sinjini Sarkar, Sushmita Ghosh, 2024, Journal of cancer research and therapeutics.

Emerging Futuristic Targeted Therapeutics

Vilas D. Nasare, N. Alam, Sinjini Sarkar, 2023, American journal of clinical oncology.